Brandt Inger, Scharpé Simon, Lambeir Anne-Marie
Laboratory of Medical Biochemistry, Department of Pharmaceutical Sciences University of Antwerp, Universiteitsplein 1, Blg S6 B-2610 Antwerp (Wilrijk), Belgium.
Clin Chim Acta. 2007 Feb;377(1-2):50-61. doi: 10.1016/j.cca.2006.09.001. Epub 2006 Oct 10.
Prolyl oligopeptidase (PO, E.C. 3.4.21.26) is a post-proline cleaving enzyme with endopeptidase activity towards peptides not longer than 30 amino acids. It has been purified and characterized from various mammalian and bacterial sources, but despite its thorough enzymological and structural characterization, the exact function of PO remains obscure. Many investigations have addressed the physiological role of this enzyme, mainly by the use of specific PO inhibitors, activity measurements in clinical samples and (neuro)peptide degradation studies. From the combined results emerges a puzzling paradox: how can an intracellular, cytoplasmatic oligopeptidase affect not only the amount of extracellular neuropeptides but also signal transduction and secretion? This report provides a review of the literature on the suggested functions for PO, highlighting possible pitfalls and contradictions.
脯氨酰寡肽酶(PO,E.C. 3.4.21.26)是一种切割脯氨酸后的酶,具有对不超过30个氨基酸的肽的内肽酶活性。它已从各种哺乳动物和细菌来源中纯化并进行了表征,但尽管对其进行了全面的酶学和结构表征,PO的确切功能仍不清楚。许多研究探讨了这种酶的生理作用,主要通过使用特异性PO抑制剂、临床样本中的活性测量以及(神经)肽降解研究。综合结果产生了一个令人困惑的悖论:一种细胞内的细胞质寡肽酶如何不仅影响细胞外神经肽的数量,还影响信号转导和分泌?本报告对关于PO假定功能的文献进行了综述,突出了可能的陷阱和矛盾之处。